| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |